[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Rapport Therapeutics' RAP-219 data is highlighted in a biotech stock news update, alongside other companies with significant clinical trial results and market movements.
Rapport Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for neurological disorders.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX +2.70%
X Month: XXXXXX +36%
X Months: XXXXXXXXX +474%
X Year: XXXXXXXXX +189%
1-Year High: XXXXXXX on 2025-09-08
1-Year Low: XX on 2025-10-26
Engagements by network (24h): X: XXX
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
X Week: XX -XX%
X Month: XXX +107%
X Months: XXXXX +486%
X Year: XXXXX +56%
1-Year High: XXX on 2025-09-08
1-Year Low: X on 2025-01-26
Mentions by network (24h): X: XX
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $rapp in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XXX +67%
X Months: XXXXX +1,187%
X Year: XXXXX +876%
1-Year High: XXX on 2025-09-08
1-Year Low: X on 2025-05-24
The most influential creators that mention $rapp in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @seedytx19 | X | XXXXX | X | XX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XXX% no change
X Month: XXX% no change
X Months: XXX% no change
X Year: XXX% +33%
1-Year High: XXX% on 2024-12-15
1-Year Low: XX% on 2025-12-02
Most Supportive Themes:
Most Critical Themes:
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"📌 Biotech Stock News 12/5 @ Open $PRAX XX% Relutrigine Results; Ulixacaltamide Pre-NDA Mtg. $VNDA X% FDA Lifts Clinical Hold on Tradipitant $CAPR X% Pricing of $150M Public Offering $BMEA X% COVALENT-111 Results @ WCIRDC $RAPP X% RAP-219 New Data $OSTX X% FDA PDUFA Waiver; EMA Marketing Eligibility $AMLX X% AMX0114 New Safety & Tolerability Data $BMY X% First CAR T Therapy Approved for MZL $NTRA X% Acquires Foresight Diagnostics $XENE X% Azetukalner 48-Month OLE Data $AAPG X% Ph3 Study of Olverembatinib Cleared $BIIB X% Zorevunersen Presentation @ AES'25 $AMRX X% CREXONT Ph4 Results $IDYA 0%"
X Link @BiopharmIQ 2025-12-05T16:40Z 28.1K followers, 4602 engagements
"Jefferies comments regarding $XENE & $RAPP for data/presentations at American Epilepsy Society 12/5-9"
X Link @medtechmd 2025-11-29T13:14Z XXX followers, XXX engagements
"Sio Capital Management Q325 13F Recap: (1/3) New: $ALKS $BBOT $CELC $CRNX $GSK $HAE $HSIC $KALV $KVUE $NVCR $RAPP $SLP $TFX Increased: $AQST $CNC $DNTH $MMS $MRK $SNY"
X Link @seedytx19 2025-11-22T21:22Z 1343 followers, 1267 engagements
"MPM BioImpact Q325 13F Recap: (1/2) New: $ASMB $ENGN $LQDA $PVLA $RAPP $SNDX $URGN Increased: $SLNO $SRPT $XENE Unchanged: $AKBA $ALKS $CGEM $CNTX $DBVT $DSGN $DYN $EWTX $HOWL $JANX $MDGL $NTRA $ORIC $PTCT $RARE $RCKT $RLAY $RNA $RPTX $RVMD $SLDB"
X Link @seedytx19 2025-11-22T00:27Z 1339 followers, 1641 engagements